Additionally, differences in the genotype/phenotype distribution were observed between the patient and historical healthy control groups (66.0%, 29.33% and 4.67% vs 76.07%, 21.76% and 2.14% for NM, IM and PM, respectively), although these differences did not reach statistical significance (codominant analysis: p=0.067 IM, p=0.112 PM; NM as reference).
← all excerpts
Association of <i>CYP2C19*2</i> c.681G>A (rs4244285) Loss-of-function Allele with Cardiovascular Disease Risk in the Kosovo Population.
1
0.0670
0.0670